Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Translations
    • Topics A-Z
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Translations
    • Topics A-Z
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Articles
  • Issues
  • Practice Current
  • Practice Buzz

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology Clinical Practice
Home
A peer-reviewed clinical neurology journal for the practicing neurologist
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Articles
  • Issues
  • Practice Current
  • Practice Buzz

Share

December 2011; 1 (1) The Nerve! Readers Speak

Amyotrophic lateral sclerosis: Ethical challengesAuthors Respond:

Claudio Crisci, Charles K. Jablecki, Wendy S. Johnston, Katelin Hoskins, Leo McCluskey
First published December 1, 2011, DOI: https://doi.org/10.1212/CPJ.0b013e31823fdda2
Claudio Crisci
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles K. Jablecki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wendy S. Johnston
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katelin Hoskins
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leo McCluskey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Amyotrophic lateral sclerosis: Ethical challengesAuthors Respond:
Claudio Crisci, Charles K. Jablecki, Wendy S. Johnston, Katelin Hoskins, Leo McCluskey
Neurol Clin Pract Dec 2011, 1 (1) 2-3; DOI: 10.1212/CPJ.0b013e31823fdda2

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
1277

Share

  • Article
  • Info & Disclosures
Loading

In the February 2011 issue of Neurology: Clinical Practice, Johnston et al.1 address the ethical issues amyotrophic lateral sclerosis (ALS) raises in a professional and compassionate manner. Nevertheless, some “unethical” thoughts come to mind. Doctors should not behave with an impersonal attitude, should be compassionate, and should not abandon patients even if faced with unacceptable requests. Is assisted suicide an unacceptable request? All of us have experienced assisting a dying patient with ALS and such a request should be addressed in a very thoughtful way. To withdraw a patient from a ventilator under a palliative sedation is more scientific and probably considered more ethical, while assisted suicide is seen as more sudden and dramatic but perhaps less devastating and less financially burdensome to the family. The economic issue sounds outrageous but insurance companies or private health care facilities are greedy. The patient had a previous tragic experience and instinctively asked for a rapid death to avoid a long-lasting agony. He knew that if he had deferred the issue to a surrogate decision-maker, it would have been impossible to respect his wish to die rapidly. The patient identified the right shortcut for him and his family from the economic and emotional point of view.

Disclosures

The author reports no disclosures.

In the February 2011 issue of Neurology: Clinical Practice, the article by Johnston et al.1 covered many ethical issues that have arisen in my practice in the evaluation and management of several hundred patients with ALS over the past 30+ years. I suggest you consider an alternative phrase to “Physicians cannot abandon patients, even if faced with unacceptable behavior or requests.” I recommend replacing it with “Physicians should try to continue to work with their patients, even in the face of behavior or requests that seem unreasonable. The request or behavior should prompt an inquiry with the hope of identifying the basis of the request or behavior with the hope of providing alternative approaches to address the patient needs that underlie the request or behavior.” There are situations where a physician should transfer care of a patient with ALS to another physician for further care. In my own practice, if a patient elects to have a tracheostomy and use continuous mechanical ventilation, I have the pulmonologist assume primary care as I do not have the experience to manage the patient's daily needs. I have not “abandoned” the patient. Finally, there are instruments to help estimate the time from the onset of weakness to the development of respiratory insufficiency leading to death.2

Disclosures

The author reports no disclosures.

Authors Respond:

We thank Dr. Crisci for his comments.

Any practitioner may be faced with a request that he or she deems unacceptable; the general principle is to look beyond the request to the impetus and to respond with empathy to the underlying motivation. To respond with compassion does not obligate a physician to comply with the request.

Most ethicists distinguish forgoing or withdrawing life-sustaining therapies from physicians hastening death (assisted suicide or euthanasia). It is debatable whether a family would regard suicide (whether physician-assisted or not) as less devastating than a planned withdrawal from a ventilator.

Initially addressing the patient's perceptions that ALS could only be a “long-lasting agony,” presenting the current interventions and strategies that improve quality of life as well as potentially extend meaningful life, may have prevented the chaos and distress that ensued. Fear of future suffering as well as concerns about burdening family are the most prominent reasons for interest in hastening death. The desire to remain autonomous and in control is also a major motivation. Physician-assisted death is legal in only a few jurisdictions; concerns that it might be viewed as “convenient” may be a motivating factor to those who oppose it.

Dr. Jablecki's thoughts and suggestions are appreciated. The positive reframing of the statement about physicians remaining available to their patients with ALS is welcome. In no way do we feel that appropriate transfer of care, in situations as you describe, represents abandonment. In fact, standard of care would suggest that all patients with ALS be offered care at a specialty multidisciplinary clinic; referral to an ALS clinic does not represent abandonment, but the original physician should not assume the other physician or clinic has taken over until the patient is actually seen or enrolled.

Thank you for drawing our attention to your article about predicting survival. Patients and families often wish to have discussions about prognosis and expectations of timing of interventions. We feel that these are appropriate when tailored to the individual and should occur only after enough information has been gathered over several clinical assessments so as to be meaningful. What we decry is the all-too-familiar statement (or variation thereof) given to patients and families at the time of diagnosis that “average survival is 2 years (or 18 months or 3 years).” In what other neurologic condition is the information so baldly conveyed? The progression of disability and timing of decisions about respiratory and nutritional interventions is highly variable. At the time of diagnosis we honestly do not know what the course will be, so we feel that it is inappropriate to convey these population-based statistics as part of breaking the news.

Disclosures

See original article for full disclosure list.

References

  1. 1.↵
    1. Johnston WS,
    2. Hoskins K,
    3. McCluskey L
    . Amyotrophic lateral sclerosis: ethical challenges. Neurology 2011;76:S1–S5.
    OpenUrlFREE Full Text
  2. 2.↵
    1. Jablecki CK,
    2. Berry C,
    3. Leach J
    . Survival prediction in ALS. Muscle Nerve 1989;12:833–841.
    OpenUrlCrossRefPubMed
  • Copyright © 2011 by AAN Enterprises, Inc.
View Abstract

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Disclosures
    • Disclosures
    • Disclosures
    • References
  • Info & Disclosures
Advertisement

Brain Metabolism Related to Mild Cognitive Impairment and Phenoconversion in Patients With Isolated REM Sleep Behavior Disorder

Dr. David E. Vaillancourt and Dr. Shannon Y. Chiu

► Watch

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published
Neurology: Clinical Practice: 13 (4)

Articles

  • Articles
  • Issues
  • Popular Articles

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology: Clinical Practice |  Print ISSN: 2163-0402
Online ISSN: 2163-0933

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise